These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8502196)

  • 1. The cardiomyopathy of Duchenne's muscular dystrophy and the function of dystrophin.
    Cziner DG; Levin RI
    Med Hypotheses; 1993 Mar; 40(3):169-73. PubMed ID: 8502196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular degeneration in Duchenne's dystrophy may be caused by a mitochondrial defect.
    Lucas-Heron B
    Med Hypotheses; 1995 Apr; 44(4):298-300. PubMed ID: 7666833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duchenne's muscular dystrophy: review and recent scientific findings.
    Evans BK; Goyne C
    Am J Med Sci; 1991 Aug; 302(2):118-23. PubMed ID: 1897557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy.
    Arahata K; Ishihara T; Kamakura K; Tsukahara T; Ishiura S; Baba C; Matsumoto T; Nonaka I; Sugita H
    N Engl J Med; 1989 Jan; 320(3):138-42. PubMed ID: 2643040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy.
    Sancho S; Mongini T; Tanji K; Tapscott SJ; Walker WF; Weintraub H; Miller AD; Miranda AF
    N Engl J Med; 1993 Sep; 329(13):915-20. PubMed ID: 8361505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing.
    Khurana TS; Prendergast RA; Alameddine HS; Tomé FM; Fardeau M; Arahata K; Sugita H; Kunkel LM
    J Exp Med; 1995 Aug; 182(2):467-75. PubMed ID: 7629506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Duchenne's myodystrophy--a hereditary defect of the cell membranes].
    Khrennikov VIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(3):22-4. PubMed ID: 1646530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The heart in muscular diseases. 1. Muscular dystrophy, especially Duchenne's muscular dystrophy].
    Beckmann R; Schmit B
    Med Klin; 1976 Jul; 71(27):1135-45. PubMed ID: 781499
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent developments in the biology of dystrophin and related molecules.
    Karpati G
    Curr Opin Neurol Neurosurg; 1992 Oct; 5(5):615-21. PubMed ID: 1392135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of dystrophin and dystrophin associated proteins.
    Michalak M; Opas M
    Curr Opin Neurol; 1997 Oct; 10(5):436-42. PubMed ID: 9330892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophin negative skeletal and myocardial muscle cells in a carrier of Duchenne's muscular dystrophy.
    Watanabe K; Izumi T; Natsui M; Matsubara N; Miyakita Y; Koyama S; Inomata T; Suzuki M; Shibata A
    Eur Heart J; 1993 Jul; 14(7):989-92. PubMed ID: 8375425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.
    Krag TO; Gyrd-Hansen M; Khurana TS
    Acta Physiol Scand; 2001 Mar; 171(3):349-58. PubMed ID: 11412148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional roles of dystrophin and of associated proteins. New insights for the sarcoglycans.
    Betto R; Biral D; Sandonà D
    Ital J Neurol Sci; 1999 Dec; 20(6):371-9. PubMed ID: 10937856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro transformation of amniotic cells to muscle cells--background and outlook].
    Streubel B; Martucci-Ivessa G; Fleck T; Bittner RE
    Wien Med Wochenschr; 1996; 146(9-10):216-7. PubMed ID: 9012220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of muscle damage.
    Jackson MJ
    Mol Cell Biol Hum Dis Ser; 1993; 3():257-82. PubMed ID: 8111542
    [No Abstract]   [Full Text] [Related]  

  • 17. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Deletion analysis of the dystrophin gene in patients with Duchenne's muscular dystrophy in Tajikistan].
    Odinokova ON; Puzyrev VP; Radzhabaliev ShF; Rakhmonov RA
    Genetika; 1996 Oct; 32(10):1392-5. PubMed ID: 9091412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell transplantation and gene therapy in muscular dystrophy.
    Morgan JE; Partridge TA
    Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscular dystrophy, mental retardation and cardiomyopathy not associated with dystrophin deficiency.
    Villanova M; Malandrini A; Biancotti R; Löfgren A; Mongini T; Six J; Salvestroni R; Parrotta E; Van Broeckhoven C; Paolozzi C; Guazzi G
    Neuromuscul Disord; 1996 May; 6(3):167-72. PubMed ID: 8784804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.